These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 14441885)

  • 21. [The quality of ergot grown in Czechoslovakia in 1960 and studies on some factors influencing the alkaloid content in field production].
    HRONES J; BLAZEK Z
    Cesk Farm; 1962 Jun; 11():239-44. PubMed ID: 14449493
    [No Abstract]   [Full Text] [Related]  

  • 22. The hydrogenated alkaloids of ergot (hydergine) in geriatrics; follow-up study.
    POPKIN RJ
    Am Pract Dig Treat; 1956 Oct; 7(10):1594-7. PubMed ID: 13362833
    [No Abstract]   [Full Text] [Related]  

  • 23. The parasitic growth of Claviceps purpurea (Fries) Tulasne on rye and its relation to alkaloid formation.
    RAMSTAD E; GJERSTAD G
    J Am Pharm Assoc Am Pharm Assoc; 1955 Dec; 44(12):741-3. PubMed ID: 13278240
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of hydrated ergot alkaloids upon carbohydrate metabolism].
    PETRIDES P; SCHAFER E
    Schweiz Med Wochenschr; 1950 Aug; 80(32):844-7. PubMed ID: 15442111
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemical assays of ergot and ergot fluidextract.
    STRONG JW; MAURINA FA
    J Am Pharm Assoc Am Pharm Assoc; 1953 Jul; 42(7):414-20. PubMed ID: 13069336
    [No Abstract]   [Full Text] [Related]  

  • 26. A NEW ERGOT ALKALOID FROM MEXICAN MAIZE ERGOT.
    AGURELL S; RAMSTAD E
    Acta Pharm Suec; 1965 Jun; 2():231-8. PubMed ID: 14326398
    [No Abstract]   [Full Text] [Related]  

  • 27. The history and present-day use of ergot.
    MOIR JC
    Can Med Assoc J; 1955 May; 72(10):727-34. PubMed ID: 14364431
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of ergot drugs for migraine.
    FUCHS M; BLUMENTAL LS
    Med Ann Dist Columbia; 1952 Jul; 21(7):372-5. PubMed ID: 14940113
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemical and pharmacological studies on the in-vitro cultured ergot. I.
    Ogiu K; Shimamoto K
    Jpn J Pharmacol; 1952 Sep; 1(1):35-43. PubMed ID: 14945926
    [No Abstract]   [Full Text] [Related]  

  • 30. [Peripheral circulation in lead poisoning patients; the action of hydrogenated alkaloids of ergot].
    ODAGLIA G; ZANNINI D
    Gazz Med Ital; 1956 Aug; 115(8):223-30. PubMed ID: 13375864
    [No Abstract]   [Full Text] [Related]  

  • 31. [Stabilization of the ergot fluid extract Ph. H. V].
    SIEGFRIED B; SCHNEIDER R
    Pharm Acta Helv; 1953 Jun; 28(6):169-77. PubMed ID: 13100000
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preparation and stabilization of ergot fluid extracts].
    GSTIRNER F; MULLER HO
    Arch Pharm Ber Dtsch Pharm Ges; 1955; 288(8-9):393-400. PubMed ID: 13303365
    [No Abstract]   [Full Text] [Related]  

  • 33. [Some psychopharmacological effects of hydrogenated extracts of ergot].
    MACHADO MR
    Sem Med; 1960 Oct; 117():1128-9. PubMed ID: 13764823
    [No Abstract]   [Full Text] [Related]  

  • 34. [ERGOT FROM WILD-GROWING GRASSES AND HYBRID PLANTS AS A POSSIBLE MATERIAL FOR SELECTION OF STRAINS OF CLAVICEPS PURPURAE TUL].
    OSTROVSKII NI; BANKOVSKAIA AN
    Med Prom SSSR; 1964 Sep; 18():46-8. PubMed ID: 14259576
    [No Abstract]   [Full Text] [Related]  

  • 35. Historical development of the ergot therapy of migraine.
    ROTHLIN E
    Int Arch Allergy Appl Immunol; 1955; 7(4-6):205-9. PubMed ID: 13306339
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reliability of the ergot test in the differential diagnosis of functional and organic ECG changes].
    ESSEN KW; SIEFERT H
    Z Kreislaufforsch; 1952 Jun; 41(11-12):430-9. PubMed ID: 14959221
    [No Abstract]   [Full Text] [Related]  

  • 37. EFFECT OF THE ERGOT INHIBITOR (CLAVICEPS PURPUREA L.) ON THE TOBACCO MOSAIC VIRUS (TMV).
    GUBANSKI M; LOWKIS L
    Acta Microbiol Pol (1952); 1964; 13():169-75. PubMed ID: 14211335
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacognosy of smooth brome ergot.
    JONES DD; TYLER VE
    J Am Pharm Assoc Am Pharm Assoc; 1955 Aug; 44(8):480-3. PubMed ID: 13242443
    [No Abstract]   [Full Text] [Related]  

  • 39. The suitability of barley as a host plant for the cultivation of ergot.
    TYLER VE
    J Am Pharm Assoc Am Pharm Assoc; 1958 Aug; 47(8):574-6. PubMed ID: 13563275
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of dehydrated ergot alkaloids (CCK 179, hydergin) in the treatment of disorders of peripheral circulation and in other sympathicotonic disorders; an analytic experiment].
    EICHLER O; HEINZEL J; LINDER F
    Klin Wochenschr; 1950 May; 28(17/18):298-304. PubMed ID: 15437776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.